Annovis Bio share price logo

Annovis Bio

NYSE: ANVS

$0.84

+0.18

(+26.31%)

as on

Annovis Bio Stock Performance

as on November 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.63
    $0.85
    downward going graph

    25.43%

    Downside

    0.60%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.62
    $5.50
    downward going graph

    27.08%

    Downside

    550.96%

    Upside

    downward going graph

Annovis Bio share price movements today

Previous Close
$0.67
Open
$0.70
Volume
8.4M
Market Cap
$28.5M
Day's Low - High
$0.63 - $0.85
52 Week Low - High
$0.62 - $5.50

Annovis Bio Historical Returns

1 Month Return
-30.17 %
3 Month Return
-55.06 %
1 Year Return
-57.76 %
3 Year Return
-85.46 %
5 Year Return
-97.68 %

Annovis Bio Stock Fundamentals & Key Indicators

Check Annovis Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.5M

EPS (TTM)

-1.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.47

Industry PE ratio

-3.22

PEG Ratio

0.42

EBITDA

-49.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-685.96%

Annovis Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Annovis Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$28.5M-97.68%-0.470.00%0.00%
Neutral$96.4B7.26%-35.9528.00%0.00%
StrongBuy$44.1BNA27.9287.82%0.00%
StrongBuy$137.5B183.69%34.9485.57%0.00%
Buy$96.3B47.88%19.2685.77%0.41%

Stock Returns calculator for Annovis Bio Stock including INR - Dollar returns

The Annovis Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Annovis Bio investment value today

Current value as on today

₹44,744

Returns

-₹55,256

(-55.26%)

Returns from Annovis Bio Stock

-₹57,755 (-57.76%)

Dollar Impact

₹2,499 (+2.5%)

Analyst Recommendation on Annovis Bio Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Annovis Bio. Average target price of $10.5

Annovis Bio Share Price Target

Get share price movements and forecasts by analysts on Annovis Bio.

What analysts predicted

91.95%UPSIDE

Target Price

$10.5

Current Price

$0.8449

Analyzed by

1 Analysts

High

$17

Target

$10.50

Low

$17

Annovis Bio target price $10.5, a slight upside of 91.95% compared to current price of $0.8449. According to 1 analysts rating.

Indian Investors' Interest in Annovis Bio Stock

Search interest for Annovis Bio Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Annovis Bio Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-14
-7
-7
-4
-6
-6
-7
-9
-18
-14
EBITDA
-14
-1
-3
-12
-5
-6
-7
-9
-17
-14
Interest Expense
-
-
1
0
-
-
-
-
-
1
Depreciation
-
-
-
0
0
0
-
-
-
-
Income Before Tax
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
0
0
-1
-6
-14
-25
-45
-26
-29
EBITDA
0
0
0
-
-14
-25
-56
-22
-28
Interest Expense
0
0
-
47
-
-
-
1
-
Depreciation
0
0
1
6
-
-
-
-
-
Income Before Tax
0
0
0
-5
-14
-25
-56
-24
-28
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
0
0
0
-5
-14
-25
-56
-24
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Operating Cash Flow
-9
-7
-3
-3
-8
-5
-3
-8
-9
-21
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
4
4
11
19
-
1
13
3
26
Change in Cash
-9
-2
0
8
11
-5
-1
4
-5
4

Annovis Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Net Income
0
0
0
-5
-14
-25
-56
-24
-28
Operating Cash Flow
0
0
0
-3
-9
-17
-39
-21
-25
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
12
46
0
17
26
34
Change in Cash
0
0
0
8
37
-17
-22
4
8

Global Institutional Holdings in Annovis Bio

Check out the Institutions with significant holdings in Annovis Bio.

Funds
Holdings
Michael B. Hoffman
8.41%
VANGUARD INDEX FUNDS
3.78%
Vanguard
3.66%
Maria-Luisa Maccecchini
2.84%
BlackRock, Inc.
0.59%

Annovis Bio News & Key Events

    Insights on Annovis Bio

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 993.6%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 245.1% return, outperforming this stock by 330.6%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, ANVS stock has moved down by -25.2%

    About Annovis Bio

    Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
    OrganisationAnnovis Bio
    Headquarters101 Lindenwood Drive, Malvern, PA, 19355, US
    IndustryBiotechnology
    CEOMaria L. Maccecchini

    Key Management of Annovis Bio

    Name

    Title

    Dr. Maria L. Maccecchini Ph.D.

    Founder, Acting CFO, CEO, President & Executive Director

    Dr. Cheng Fang Ph.D.

    Chief Scientific Officer

    Ms. Eve M. Damiano M.S., RAC

    Senior Vice President of Regulatory Operations

    Mr. Blake Jensen M.B.A.

    Head of Quality

    Ms. Hilda Maibach

    Senior Vice President of Statistics

    FAQs

    What is Annovis Bio share price today?

    Annovis Bio share price today is $0.84 as on at the close of the market. Annovis Bio share today touched a day high of $0.85 and a low of $0.63.

    What is the 52 week high and 52 week low for Annovis Bio share?

    Annovis Bio share touched a 52 week high of $5.50 on and a 52 week low of $0.62 on . Annovis Bio stock price today i.e. is closed at $0.84,which is 84.64% down from its 52 week high and 37.14% up from its 52 week low.

    What is Annovis Bio's market capitalisation today?

    Annovis Bio market capitalisation is $0.00T as on .

    How to invest in Annovis Bio Stock (ANVS) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Annovis Bio on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Annovis Bio Stock (ANVS) from India?

    Indian investors can start investing in Annovis Bio (ANVS) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹939.10 in Annovis Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Annovis Bio share’s latest price of $0.84 as on November 7, 2026 at 8:46 am IST, you will get 11.8357 shares of Annovis Bio. Learn more about fractional shares .

    What are the returns that Annovis Bio has given to Indian investors in the last 5 years?

    Annovis Bio stock has given -97.68% share price returns and 27.93% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?